NanoVibronix Inc: Rises on licensing deal for ultrasound system

SANUWAVE Health

02/04/2020 15:16

** Shares of medical device maker  NAOV.O  rise 4.2% to
$2.44
    ** Company signs license agreement with regenerative therapy
provider Sanuwave Health Inc  SNWV.PK  for manufacture and
delivery of NAOV's ultrasound system, WoundShield  urn:newsml:reuters.com:*:nPn4gXQfqa
    ** Under the terms of agreement, NAOV will receive 100,000
warrants of SNWV stock, $250,000 as milestone payment based on
FDA approval, and 10% royalty on Sanuwave's gross revenues from
sales or rentals of WoundShield
    ** Sanuwave says it now has worldwide exclusive rights to
WoundShield and will bear the costs associated with FDA
approvals and other global regulators
    ** Including session's gain, NAOV down ~14% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))